Skip to content

High disease activity and prednisone use during pregnancy; lifelong consequences for children of mothers with rheumatoid arthritis?

High disease activity and prednisone use during pregnancy; lifelong consequences for children of mothers with rheumatoid arthritis? - FEtal Programming by Rheumatoid Arthritis (FEPRA)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40087
Enrollment
378
Registered
2009-12-21
Start date
2010-10-13
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic systemic inflammatory disorder

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: mother has participated in the PARA study (MEC 214.320/2002/117)

Exclusion criteria

Exclusion criteria: a) twins b) non-Caucasian children c) children with congenital abnormalities

Design outcomes

Primary

MeasureTime frame
Anthropometric data of the child - Height - Weight - Sitting height - Head circumference - Arm/waist/hip circumference Blood pressure of the child - 3 times measurement on one day Parents: - weight - height - head circumference - blood pressure Information on: - Familiy medical hisory - Medication use of mother - Growth chart from birth onwards

Secondary

MeasureTime frame
Data on body composition & fat percentage - Lean body mass - Holtain skin fold caliper - Abdominal ultrasound - Dual Energy X-ray Absorptiometry (DXA) Venapuncture - glucose - glucose fasting levels - C-peptide - Insulin - Cortisol - Total cholesterol - HDL - LDL - Triglycerides - Free fatty acid - Adiponectin - DNA analysis (genetic variation and epigenetic changes) 24 h cortisol levels in saliva - 4 measurements on one day Buccal epithelial cells obtained by mouth swab - DNA analysis, 1 measurement

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)